Neurologic complications of COVID-19.
Where this comes from
- Record sourced from PubMed, PMID 32847818.
- Also identified by DOI 10.3949/ccjm.87a.ccc058.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with COVID-19 have a fairly high risk of neurologic complications, including encephalopathy, stroke, central nervous system infection, seizures, and neuromuscular diseases. Many report losing their senses of smell and taste, and many survivors report lingering neurocognitive impairment. The diagnosis and treatment of these complications does not differ from that in other patients, although sophisticated testing may not be readily available for a patient in intensive care and respiratory isolation. Clinicians should therefore be alert to these complications.
Medical subject headings
- COVID-19
- Central Nervous System Diseases
- Neuromuscular Diseases
- SARS-CoV-2
- Seizures
- Stroke